Game Over: Lilly’s “Videogame” Ad For Strattera Confuses Message, FDA Says
This article was originally published in The Pink Sheet Daily
Executive Summary
The fast-paced presentation of various scenes through a videogame screen, plus the running score, scrolling text and “eerie sound effects,” confuse the presentation of the attention deficit disorder indication and minimize risk information, FDA’s ad division says.
You may also be interested in...
Strattera Ad Division Letter “Unsubstantiated,” WLF Says
FDA has no evidence to support its claims that a recent Lilly Strattera (atomoxetine) TV ad is misleading, the Washington Legal Foundation said
Strattera Ad Division Letter “Unsubstantiated,” WLF Says
FDA has no evidence to support its claims that a recent Lilly Strattera (atomoxetine) TV ad is misleading, the Washington Legal Foundation said
ADHD Market Hurt By Safety Concerns, Lilly Says
Strattera marketer says that label change and withdrawal of Shire's Adderall XR in Canada has slowed the growth of the attention deficit/hyperactivity disorder market. Lilly will focus on consumers with new DTC ad designed to encourage adult patients to seek treatment.